NCT02376257View on ClinicalTrials.gov

Improving Therapeutic Learning in Depression: Proof of Concept

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 16, 2014

Primary Completion Date

April 21, 2017

Study Completion Date

May 31, 2017

Conditions
Major Depressive Disorder
Interventions
DRUG

250 mg DCS

Drug

DRUG

100 mg Modafinil

Drug

DRUG

Placebo

Drug

Trial Locations (1)

02215

Boston University, Boston

All Listed Sponsors
lead

Boston University Charles River Campus

OTHER

NCT02376257 - Improving Therapeutic Learning in Depression: Proof of Concept | Biotech Hunter | Biotech Hunter